influenza vaccine (seasonal adjuvant)

Influenza vaccine (seasonal adjuvant) refers to a seasonal influenza vaccine formulation that incorporates an adjuvant to enhance the immune response, particularly in populations with reduced vaccine responsiveness such as the elderly. In the context of Vaxine Pty Ltd and the VaxCelerate Consortium, this specifically refers to a vaccine candidate utilizing the proprietary Advax adjuvant. Advax is a unique polysaccharide adjuvant derived from delta inulin that enhances both humoral (antibody) and cellular (T-cell) immunity without the high levels of inflammation associated with traditional adjuvants. The vaccine typically targets multiple strains of Influenza A (such as H1N1 and H3N2) and Influenza B, aiming to provide superior protection and potentially broader cross-reactivity against seasonal viral variants.

Other names

Advax-adjuvanted seasonal influenza vaccinedelta inulin-adjuvanted influenza vaccineinfluenza vaccine (seasonal adjuvant)